Related Experiment Video
Updated: Jul 12, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
NLRP3 inflammatory pathway. Can we unlock depression?
Ghazaleh Ghaffaripour Jahromi1, Sepideh Razi2, Nima Rezaei3
1Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran; Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Depression is a leading cause of disability. This review highlights how NLRP3 inflammasome activation drives inflammation in the brain and body, offering new therapeutic targets for depression.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Depression is a major global health issue, causing significant disability.
- Current diagnostic biomarkers and treatments for depression are insufficient for many patients.
- Existing pathophysiological models do not fully explain depression's complexity.
Purpose of the Study:
- To review the role of NLRP3 inflammasome activation in depression.
- To explore the connection between inflammation and depression pathophysiology.
- To identify potential therapeutic targets within the NLRP3 inflammasome pathway.
Main Methods:
- Comprehensive literature review of established pathophysiological models of depression.
- Analysis of human and animal studies investigating NLRP3 inflammasome activation in depression.
- Examination of the impact of NLRP3 inflammasome on CNS, enteric, and peripheral systems.
Main Results:
- NLRP3 inflammasome activation is a key driver of inflammation implicated in depression.
- Inflammation affects CNS cells (neurons, astrocytes, microglia), the microbiota-gut-brain axis, and barrier integrity (BBB, IEB).
- Dysregulation extends beyond the CNS to enteric and peripheral immune systems.
Conclusions:
- NLRP3 inflammasome activation represents a unifying pathophysiological mechanism in depression.
- Targeting the NLRP3 inflammasome pathway offers potential for novel depression treatments.
- Further research into modulating this pathway could lead to more effective depression management.
Related Concept Videos
G-protein Coupled Receptors
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Regulation of the Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

